CircNova, a Michigan-based biotech startup, has completed a $3.3 million seed round to advance its technology, which uses artificial intelligence to target circular RNA. The aim is to treat diseases such as ovarian cancer and rare genetic diseases.

CircNova is a Michigan-based biotech startup that focuses on developing AI-driven circular RNA therapies. Co-founded by Crystal Brown and Joe Deangelo, the company has created a proprietary AI engine for the identification and production of novel circular RNAs. The company aims to treat diseases that have previously lacked effective therapies, such as ovarian cancer and neurodegenerative diseases.

https://www.circnova.com/

CircNova raised $3.3M in a seed round to advance its AI-driven circular RNA therapies.

Description

Company Information

Related People

CircNova raised $3.3M in a seed round to advance its AI-driven circular RNA therapies.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information